Explore treatment areas with clear expectations.

Rhinoplasty changes nasal bone, cartilage, soft tissue, or a combination of these structures. Planning may address appearance, breathing, prior injury, or revision concerns, but cosmetic and functional goals must be separated clearly.

Asian rhinoplasty is not one standardized operation. The consultation should begin with the patient’s own anatomy and preferences, including whether the goal involves bridge height, tip support, width, projection, breathing, or no surgery at all.

Facelift surgery repositions selected facial and neck tissues; it does not stop aging or change every feature. The operative plan may differ substantially depending on where laxity is present and whether the neck, eyelids, brow, or skin surface also needs discussion.

A brow or forehead lift addresses brow position and selected forehead tissues. It should be distinguished from eyelid surgery, wrinkle treatments, and a desire to change the natural shape of the eyes.

Neck-lift planning may address skin laxity, fat distribution, muscle bands, or jawline transition. The source of fullness or laxity matters because skin removal, liposuction, and muscle treatment do different things.

Blepharoplasty treats selected upper- or lower-eyelid tissues. The surgeon must distinguish excess skin, fat position, brow descent, dry-eye symptoms, and functional visual-field concerns before recommending a plan.

Asian eyelid surgery is individualized around crease presence, height, continuity, eyelid fat, skin, levator function, and the patient’s identity. A crease is not automatically desirable and no single crease design fits every person.

Cheek-reduction requests can refer to bone width, buccal fat, masseter muscle, or overall facial proportions. These are different anatomical issues with different risks, and the office must first verify that this service is currently offered.

Jaw-reduction planning must distinguish skeletal width, bite relationship, masseter muscle size, and soft tissue. It is not interchangeable with orthognathic surgery or a non-surgical muscle treatment.

Chin augmentation changes projection or contour using an implant or, in some cases, bone repositioning or filler. The plan should account for bite, jaw relationships, lip posture, and the profile as a whole.

Profile surgery is a planning concept, not one procedure. It may involve the nose, chin, neck, jaw, or no operation, and each component should have its own indication, alternatives, risks, and recovery plan.

Forehead contouring may refer to bone, soft tissue, hairline, or brow relationships. Because this can range from minor contour discussion to craniofacial bone surgery, the office must verify scope and service availability before publishing technique claims.

Otoplasty reshapes or repositions selected ear cartilage. The plan depends on ear projection, fold formation, conchal depth, asymmetry, prior surgery, and the patient’s age and goals.

Breast augmentation uses an implant or fat transfer to change volume and shape. Implant choice is a long-term medical-device decision requiring the FDA patient decision checklist, ongoing follow-up, and discussion of future imaging or surgery.

Breast reduction removes and reshapes breast tissue and skin to reduce size or related symptoms. The plan considers symptoms, breast composition, nipple position, scars, sensation, future pregnancy, and breastfeeding goals.

A breast lift reshapes and elevates existing breast tissue by removing skin and repositioning the nipple; it does not reliably add upper-pole volume. Augmentation or reduction is a separate decision.

Liposuction removes selected deposits of subcutaneous fat; it is not a weight-loss treatment and does not reliably tighten loose skin. Contour depends on skin quality, anatomy, technique, and stable weight.

Abdominoplasty removes selected abdominal skin and may tighten separated abdominal fascia. It is not a weight-loss operation and does not remove internal visceral fat.

Gluteal fat grafting transfers fat to the buttocks and carries unique safety concerns, including fatal fat embolism. This service must remain inactive on the public site until the office confirms it is offered and documents its technique and safety policy.

“Mommy makeover” is a marketing label for a customized combination of procedures, often involving the abdomen and breasts. Each component needs a separate indication, consent, risk discussion, and decision about whether combining operations is appropriate.

Labiaplasty changes selected labial tissue. Normal anatomy varies widely, so consultation should distinguish physical symptoms, asymmetry, appearance concerns, sexual function, and external pressure or expectations.

Body contouring may combine fat removal, skin excision, or staged operations across more than one region. The page is a planning overview, not a promise that every area should be treated together.

After major weight loss, excess skin may affect more than one body region and can cause hygiene, mobility, clothing, or contour concerns. Safe planning usually prioritizes weight stability, nutrition, scars, staging, and recovery support.

Panniculectomy removes an overhanging lower-abdominal pannus. It is distinct from cosmetic abdominoplasty because the primary goal may be hygiene, skin symptoms, mobility, or function rather than muscle tightening or waist contour.

Brachioplasty removes selected upper-arm skin and may include fat reduction. It trades improved contour for a permanent scar whose length and position depend on the amount and location of laxity.

Thigh lift surgery removes selected thigh skin and may reshape underlying tissue. Scar location, friction, wound tension, and lower-body mobility are central planning issues.

A lower-body lift addresses circumferential skin laxity around the abdomen, flanks, buttocks, and sometimes thighs. It is an extensive operation with long scars, mobility needs, and meaningful wound and clot risk.

Botulinum toxin temporarily reduces selected muscle activity. It does not fill folds, tighten loose skin, or treat every type of facial line, and product selection and dosing require a licensed clinician.

This legacy “Botox MedSpa” route duplicates botulinum-toxin education and is not verified as a separate active service. It should remain non-indexable or redirect to a reviewed neuromodulator page after office approval.

Hyaluronic-acid filler can add or redistribute volume in selected facial areas. Juvéderm is a product family, not one universal treatment; product, anatomy, injection plane, and vascular safety all matter.

LATISSE is a prescription bimatoprost product for eyelash growth, not a general cosmetic service. This legacy route remains inactive until the office verifies current prescribing workflow and medical review.

Dermabrasion mechanically resurfaces selected skin layers. Depth, skin type, pigment response, scar history, and the condition being treated determine both potential benefit and recovery.

Chemical peels create a controlled skin injury to address selected surface concerns. Superficial, medium, and deep peels have very different indications, recovery, and pigment or scarring risks.

“Triniti” is a legacy branded treatment label whose current device, indications, and office availability are not verified. It remains inactive and non-indexable until the exact technology and claims are reviewed.

Scar revision aims to improve a scar’s appearance, comfort, or function; it cannot erase a scar. Treatment differs for raised, depressed, widened, pigmented, contracted, or symptomatic scars.

Reconstructive surgery is a broad category for restoring form or function after congenital difference, trauma, burn, cancer treatment, infection, or prior surgery. A specific diagnosis and goal are required before technique or recovery can be described.